Partner and head of UK antitrust and competition practice specialising in UK and EC competition law, including merger control, joint ventures and other commercial arrangements, and also contentious matters such as cartels and abuse of market power inquiries. Also advises on competition and regulatory issues in relation to the regulated utilities with particular experience in the media, telecommunications, financial services and energy sectors.
564
The first State aid measures authorized by the European Commission (Commission) following the COVID-19 outbreak were aimed at helping companies to cover their immediate liquidity needs, mainly through bank loans guaranteed by EU Member States. The significant losses incurred by companies as (...)
172
The current COVID-19 pandemic is posing unprecedented challenges on our public health systems and communities. It is also heavily impacting economic activity, including for companies in the midst of M&A or joint venture transactions. Deals that are subject to merger control review in the (...)
127
On 3 December 2003, the Competition Appeal Tribunal in the UK upheld an application by IBA Health Ltd for judicial review against the Office of Fair Trading’s decision not to refer the anticipated merger between iSoft Plc and Torex Plc to the Competition Commission for detailed investigation. (...)
377
On 3 December 2003, the Competition Appeal Tribunal in the UK upheld an application by IBA Health Ltd for judicial review against the Office of Fair Trading’s decision not to refer the anticipated merger between iSoft Plc and Torex Plc to the Competition Commission for detailed investigation. (...)
